Inositol-recognizing proteins (IPRPs)

Inositol-recognizing proteins (IPRPs) constitute a diverse family of proteins characterized by their ability to specifically bind inositol phosphates (such as IP3, IP4, IP5, and IP6) and phosphoinositides (such as PIP2 and PIP3). This group includes critical signaling molecules like the inositol 1,4,5-trisphosphate receptors (IP3Rs), which function as ligand-gated calcium channels on the endoplasmic reticulum, and adaptor proteins such as AP-2 and AP-180, which are essential for clathrin-mediated endocytosis. These proteins play fundamental roles in intracellular signal transduction, calcium homeostasis, and vesicle trafficking, making them vital for cellular communication and maintenance. Dysregulation of inositol-recognizing proteins is implicated in a wide range of pathologies, including various cancers, neurodegenerative diseases like Alzheimer's, and mood disorders such as bipolar disorder. While few drugs target this entire class, specific members like IP3Rs are the focus of drug discovery efforts, and compounds like lithium indirectly modulate the system by depleting the cellular inositol pool. Research tools such as 2-APB and xestospongin C are commonly used to study the pharmacological inhibition of these proteins, particularly in the context of calcium signaling.

Other names

Inositol polyphosphate-recognizing proteinsInositol phosphate-binding proteinsInositol receptorsPhosphoinositide-binding proteins

Modulation of intracellular calcium release via IP3 receptors, inhibition of clathrin-mediated endocytosis, and depletion of cellular inositol pools.